Protalix BioTherapeutics, Inc. (NYSEMKT:PLX)
A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
EBStroke
(< 20)
Submitted: 4/22/2013 1:35:57 PM :
Start Price:
$5.54
PLX Score:
+13.24
Zacks Rank 5-StrongSell, Recommend Neutral, Industry Rank 93 / 265, Avg target of 4 analysts 6.17
- Short Interest Ratio: 8.00 %
- Est Revision Ratio: Up 0 vs 4 Down
Recs
zzlangerhans
(99.77)
Submitted: 8/19/2012 2:05:17 AM :
Start Price:
$5.50
PLX Score:
-23.03
I always get an uneasy feeling when I green thumb a stock like Protalix because I don't trust the company and I especially don't trust former chairman Philip Frost. Does he still have his fingers in this pie? Your guess is as good as mine. As far as I'm concerned, nothing he is involved with is investment grade. That being said, the company has managed to get a potentially lucrative drug approved and they have the ability to compete with the established therapies due to lower manufacturing costs. This could certainly blow up disastrously but I'm willing to kick in an outperform pending initial sales data.
Recs
TMFBiologyFool
(99.09)
Submitted: 5/2/2012 12:24:24 PM :
Start Price:
$7.02
PLX Score:
+44.96
Low patient numbers + 2 competitors = tough launch.
I actually like the manufacturing technology, but next drug is still years away.
Recs
sunvestor7
(< 20)
Submitted: 3/10/2012 5:47:39 PM :
Start Price:
$5.55
PLX Score:
-27.67
the disruptive technology that will change the biologics. They have had setbacks ---but their time now has come. With approval for gaucher and validation of technology platform sky is the limit
Recs
YORGILL
(< 20)
Submitted: 3/11/2011 2:05:26 PM :
Start Price:
$6.25
PLX Score:
-44.69
Great innovative platform with big potential for biosimilars
Recs
reachmygoals1
(< 20)
Submitted: 1/29/2011 4:23:49 PM :
Start Price:
$9.28
PLX Score:
-74.31
$20 after fda approval...over $30 if they get a buyout after fda approval
Recs
eitanbilu
(< 20)
Submitted: 12/8/2010 11:22:53 AM :
Start Price:
$8.68
PLX Score:
-76.00
no doubts !
Recs
RXDOC73
(99.14)
Submitted: 8/30/2010 9:44:30 AM :
Start Price:
$7.79
PLX Score:
-89.74
Great positioning to take on high cost generic specialty medications. Possible buy out by PFE?
Recs
Recs
luebypopoff
(28.80)
Submitted: 12/30/2009 7:37:33 PM :
Start Price:
$6.70
PLX Score:
-70.42
Shorts are driving stock down, but has deal with Pfizer, a new drug about to be released, and others in the pipeline.
Recs
movadoman51
(< 20)
Submitted: 11/4/2009 12:37:36 AM :
Start Price:
$10.93
PLX Score:
-110.64
New technology!!! will bit all pharma co.
Recs
Displacement
(< 20)
Submitted: 9/28/2009 4:24:48 PM :
Start Price:
$8.27
PLX Score:
-93.85
Surprising performance for my contrarians' box
Recs
Thelmal
(44.25)
Submitted: 9/25/2009 8:07:36 AM :
Start Price:
$7.60
PLX Score:
-90.89
Forward thinking Biotech Company
Recs
hrefael77
(< 20)
Submitted: 9/2/2009 1:19:08 PM :
Start Price:
$7.10
PLX Score:
-94.06
SUCCESEE IN THE iii PHASE
Recs
yshoshany
(< 20)
Submitted: 7/24/2009 9:25:07 AM :
Start Price:
$6.20
PLX Score:
-88.61
great technology
Recs
LandWayland
(< 20)
Submitted: 7/17/2009 8:15:38 PM :
Start Price:
$5.48
PLX Score:
-82.31
This company has developed a radical new technology for cheaply generating biological components for making complex drugs. Their first drug has successfully completed FDA Phase III trials and will soon be on the market with a potential annual sales in excess of $1 billion.
Recs
floyd28
(< 20)
Submitted: 7/16/2009 11:11:08 PM :
Start Price:
$5.56
PLX Score:
-84.80
Protalix is re inventing the wheel and that means it will be probably bought by a bigger company in a high price which will make the holders happy.
If it wont be bought (or wont be sold) then I personally believe it will be a major player and the stock's price right now will sound like a joke in a few years from now.
A risk, yes! but today most investments have risks within them at least here we know that the reward can be worthwhile.
That is my personal opinion only - not a recommendation!
Recs
esqdrew
(< 20)
Submitted: 6/27/2009 8:20:16 PM :
Start Price:
$4.90
PLX Score:
-75.97
Because Philip Frost is involved and because PLX is in Phase III of its testing of prGCD and if the results turn out well this stock will explode.
Recs
crapsshooter
(84.67)
Submitted: 2/13/2009 12:21:14 PM :
Start Price:
$2.64
PLX Score:
-6.90
There have been no Serious Adverse Events reported in connection with the phase III clinical trial. I bought in at 1.38 and this has been going up so therefore i am going very long
Recs
yellowear
(31.89)
Submitted: 12/20/2008 12:32:36 PM :
Start Price:
$1.62
PLX Score:
+131.42
Based on the news on the street and the performance of the stock at these levels, this company has the potential of reaching 2000% in the next 4 years. This stock has found a bottom like AKS did several years ago which reached a high of 70+ before it cratered. This is a 'Just about Perfect' time to start to buy this stock!
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 34 : 1 2 Next »